Vin Arx Pharmaceuticals Private Limited

Vin Arx Pharmaceuticals Private Limited - pharma in Panchkula, Haryana, India. FY 2026 financials & compliance.
CIN U51909HR2022PTC101549 Incorporated 22 February 2022 ROC Delhi HQ Panchkula, Haryana, India
Active Private Limited Company pharma
Revenue · FY 2025
₹1.75 Cr
▲ 197% YoY
Net profit · FY 2025
₹1.39 Lakh
Net margin 0.8%
EBITDA · FY 2025
₹3.69 Lakh
EBITDA margin 2.1%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹9.6 Lakh
Issued & subscribed
Open charges
₹50 Lakh
Secured borrowings
Company age
4 yrs
Est. 2022
Directors on board
2
As per MCA filings

About Vin Arx Pharmaceuticals Private Limited

Data last updated:

Vin Arx Pharmaceuticals Private Limited is a private limited company based in Panchkula, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 February 2022.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909HR2022PTC101549. Its GSTIN is 06AAICV5736F1Z6 (Haryana).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹9.6 Lakh. It is led by directors Gaurav Gupta and Sorabh Gupta.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 274 Industrial Area Phase – 1, Panchkula, Haryana, India – 134113.

As per the financials filed for FY 2025, the company reported a revenue of ₹1.75 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1.39 Lakh (net margin 0.8%) and EBITDA of ₹3.69 Lakh (EBITDA margin 2.1%).

As per MCA filings, the company has open charges of ₹50 Lakh on record. Court records list 2 cases involving the company, including 2 filed by the company; 1 case is pending.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U51909HR2022PTC101549
Registration Number 101549
Incorporation Date 22 February 2022
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

Vin Arx Pharmaceuticals Private Limited's registered office is in Panchkula, Haryana. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Plot No. 274 Industrial Area Phase – 1, Panchkula, Haryana, India – 134113
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Vin Arx Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Vin Arx Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Vin Arx Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Vin Arx Pharmaceuticals Private Limited, buy the company report.

Financials of Vin Arx Pharmaceuticals Private Limited

FY 2025 filings available

Vin Arx Pharmaceuticals Private Limited reported revenue of ₹1.75 Cr (up 197% YoY) for FY 2025.

Revenue · FY 2025
₹1.75 Cr ▲ 197%
Net profit · FY 2025
₹1.39 Lakh margin 0.8%
EBITDA · FY 2025
₹3.69 Lakh margin 2.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 197%
EBITDA CAGR growth
1 year
▲ 76%

Revenue rose 197% in the latest year. EBITDA rose 76% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹3.69 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1.39 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin2.1%
Net Profit Margin0.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Vin Arx Pharmaceuticals Private Limited, buy the company report.

Board of directors of Vin Arx Pharmaceuticals Private Limited

Vin Arx Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Gaurav GuptaDirector22 Feb 20224 Years 8 MonthsCurrent
Sorabh GuptaDirector22 Feb 20224 Years 8 MonthsCurrent

Peer comparison

Vin Arx Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Stoicure Pharmaceuticals Private Limited₹1.76 Cr (FY 2024)432.0%Ahmedabad, Gujarat, India
Vin Arx Pharmaceuticals Private Limitedthis company₹1.75 Cr (FY 2025)₹1.39 Lakh0.8%197.0%Panchkula, Haryana, India
Shrijan Pharmaceuticals Private Limited₹1.74 Cr (FY 2024)11.0%Uttar Pradesh, India
Sandmartin Pharmaceuticals Private Limited₹1.74 Cr (FY 2025)16.0%New Delhi, Delhi, India
Aanyas Pharmaceuticals India Private Limited₹1.73 Cr (FY 2024)4.0%Raipur, Chhattisgarh, India

To see the full peer comparison of Vin Arx Pharmaceuticals Private Limited, buy the company report.

Auditor

Vin Arx Pharmaceuticals Private Limited is audited by KBB & CO. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
KBB & CO.FY 2023023819N

Shareholding

The shareholding of Vin Arx Pharmaceuticals Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Vin Arx Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹50 Lakh
Satisfied charges
None
Breakdown by lending institutions
Others₹0.50 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
09 Mar 2023100720983Others₹50 LakhOpen

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Vin Arx Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Vin Arx Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
06AAICV5736F1Z6HaryanaActive15 Jan 2023

To see the full GST registrations and return filing status of Vin Arx Pharmaceuticals Private Limited, buy the company report.

Recent activity

Vin Arx Pharmaceuticals Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Gaurav Gupta was appointed as Director on 22 Feb 2022.

AGM
Vin Arx Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Vin Arx Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Others amounted to Rs. 50.00 Lakh with Charge ID 100720983 was registered on 09 Mar 2023.
Appointed
Gaurav Gupta was appointed as Director.
Appointed
Sorabh Gupta was appointed as Director.
Incorporation
22 Feb 2022
Vin Arx Pharmaceuticals Private Limited was registered on 22 Feb 2022 with Roc Delhi & aged 4 years 8 months as per MCA records.

Frequently asked questions

Vin Arx Pharmaceuticals is an active private limited company based in Panchkula, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 February 2022 (4+ years old) and is registered under CIN U51909HR2022PTC101549.

Vin Arx Pharmaceuticals has 2 current directors:

The latest financial statements of Vin Arx Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.

The GSTIN of Vin Arx Pharmaceuticals is 06AAICV5736F1Z6, registered in Haryana.

The CIN (Corporate Identification Number) of Vin Arx Pharmaceuticals is U51909HR2022PTC101549. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Vin Arx Pharmaceuticals has 2 court cases on record: 2 filed by the company. 1 is pending.

Vin Arx Pharmaceuticals was incorporated on 22 February 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Vin Arx Pharmaceuticals by revenue are Stoicure Pharmaceuticals Private Limited, Shrijan Pharmaceuticals Private Limited, Sandmartin Pharmaceuticals Private Limited, Aanyas Pharmaceuticals India Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).

Gaurav Gupta was appointed as Director on 22 Feb 2022. Sorabh Gupta was appointed as Director on 22 Feb 2022.

The registered office of Vin Arx Pharmaceuticals is at Plot No. 274 Industrial Area Phase – 1, Panchkula, Haryana, India – 134113.

Vin Arx Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.